The Effect of CPC on Aborting Tilt Induced Syncope in Patients With a History of Vasovagal Syncope
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
Syncope is defined as transient loss of consciousness associated with inability to maintain
postural tone with rapid and spontaneous recovery. The purpose of this study is to assess the
effects of sublingual administration of a new medication called CPC on tilt-induced syncope
in patients with a history of vasovagal syncope (VVS). 132 participants will be enrolled at
the University of Wisconsin - Madison. Each participant will be in the study for 1 day.